--- title: "This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday" type: "News" locale: "en" url: "https://longbridge.com/en/news/299444479.md" description: "Wall Street analysts initiated bullish coverage on five stocks: TRAX, BGSI, NPCE, CUE, and NGVC. Evercore ISI rated TRAX Outperform with a $65 target; Mizuho rated BGSI Outperform at $120; Keybanc rated NPCE Overweight at $18; B. Riley rated CUE Buy at $83; and BofA rated NGVC Buy at $35." datetime: "2026-09-18T11:53:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299444479.md) - [en](https://longbridge.com/en/news/299444479.md) - [zh-HK](https://longbridge.com/zh-HK/news/299444479.md) generator: "portal-rs" --- # This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. - Evercore ISI Group initiated coverage on **First Tracks Biotherapeutics Inc** (NASDAQ:TRAX) with an Outperform rating and announced a price target of $65. First Tracks closed at $39.20 on Thursday. See how other analysts view this stock. - Mizuho analyst David Bellinger initiated coverage on **Boyd Group Services Inc** (NYSE:BGSI) with an Outperform rating and announced a price target of $120. Boyd Group shares closed at $81.00 on Thursday. See how other analysts view this stock. - Keybanc analyst Brett Fishbin initiated coverage on **Neuropace Inc** (NASDAQ:NPCE) with an Overweight rating and announced a price target of $18. NeuroPace closed at $14.15 on Thursday. See how other analysts view this stock. - B. Riley Securities analyst Mayank Mamtani initiated coverage on **Cue Biopharma Inc** (NASDAQ:CUE) with a Buy rating and announced a price target of $83. Cue Biopharma shares closed at $37.84 on Thursday. See how other analysts view this stock. - B of A Securities analyst Vicky Liu initiated coverage on **Natural Grocers by Vitamin Cottage Inc** (NYSE:NGVC) with a Buy rating and announced a price target of $35. Natural Grocers closed at $29.32 on Thursday. See how other analysts view this stock. Considering buying CUE stock? Here’s what analysts think: *Photo via Shutterstock* ### Related Stocks - [BGSI.US](https://longbridge.com/en/quote/BGSI.US.md) - [CUE.US](https://longbridge.com/en/quote/CUE.US.md) - [NGVC.US](https://longbridge.com/en/quote/NGVC.US.md) - [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md) - [NPCE.US](https://longbridge.com/en/quote/NPCE.US.md) ## Related News & Research - [NeuroPace, Inc. (NPCE) - What Are Brokerages Saying About This Stock?](https://longbridge.com/en/news/302202439.md) - [QV Investors Inc. Acquires New Shares in Natural Grocers by Vitamin Cottage, Inc. $NGVC](https://longbridge.com/en/news/302537577.md) - [Natural Grocers Shareholders Approve Reincorporation From Delaware to Texas](https://longbridge.com/en/news/302467863.md) - [Neptune Insurance Q3 net income jumps 50% on strong premium growth](https://longbridge.com/en/news/302464341.md) - [First Tracks Biotherapeutics Closes Private Placement of 6,106,870 Shares](https://longbridge.com/en/news/302462194.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**